| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 78706 |
Maleimido-mono-amide-DOTA（CAS号：1006711-90-5） |
194 |
WYQ |
2024-12-19 |
| 78707 |
cas:2055041-40-0，Azido-PEG1-Val-Cit-PAB-OH，叠氮-一聚乙二醇-VAL-CIT-PAB-羟基 |
92 |
kx |
2024-12-19 |
| 78708 |
MB-VC-MGBA CAS号：932744-62-2 |
162 |
WYQ |
2024-12-19 |
| 78709 |
Anti-GPNMB-VC-MMAE-ADC抗体偶联药物 |
121 |
zyl |
2024-12-19 |
| 78710 |
MA-PEG8-VA-PAB-SG3199，硫醇反应SET™毒素 |
173 |
WYQ |
2024-12-19 |
| 78711 |
cas:1662687-83-3 ， Mal-PEG2-Val-Cit-PABA，马来酰亚胺-二聚乙二醇-VAL-CIT-PABA |
105 |
kx |
2024-12-19 |
| 78712 |
Boc-Val-Ala-PAB cas:1884577-99-4 |
139 |
zyl |
2024-12-19 |
| 78713 |
perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate |
101 |
wyh |
2024-12-19 |
| 78714 |
MA-PEG4-VA-PBD（CAS号：2259318-50-6） |
137 |
WYQ |
2024-12-19 |
| 78715 |
SPDP-Val-Cit-PAB-PNP-ADC抗体偶联药物 |
173 |
zyl |
2024-12-19 |
| 78716 |
cas:1438853-35-0，Mal-PEG3-Val-Cit-PAB-PNP，马来酰亚胺-三聚乙二醇-VAL-CIT-PAB-PNP 酯 |
120 |
kx |
2024-12-19 |
| 78717 |
Mc-vc-PABC-SP 141，一种用于抗体药物偶联物（ADC）合成的linker或连接臂 |
133 |
WYQ |
2024-12-19 |
| 78718 |
perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate |
151 |
wyh |
2024-12-19 |
| 78719 |
cas:2055041-37-5，Mal-PEG1-Val-Cit-PAB-OH，马来酰亚胺-一聚乙二醇-VAL-CIT-PAB-羟基 |
135 |
kx |
2024-12-19 |
| 78720 |
perfluorophenyl 15-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-13-oxo-3,6,9-trioxa-12-azapentadecan-1-oate |
118 |
wyh |
2024-12-19 |
| 78721 |
MC-Val-Cit-PAB-PNP cas:159857-81-5 |
133 |
zyl |
2024-12-19 |
| 78722 |
NAMPT-linker（CAS号：2241019-57-6） |
114 |
WYQ |
2024-12-19 |
| 78723 |
cas:103848-61-9，6-Maleimidocaproic acid sulfo-NHS |
126 |
wyh |
2024-12-19 |
| 78724 |
cas:159857-80-4 ，MC-Val-Cit-PAB-OH， ADC（抗体偶联药物 ） |
120 |
kx |
2024-12-19 |
| 78725 |
Boc-Val-Cit cas:870487-08-4 |
154 |
zyl |
2024-12-19 |
| 78726 |
cas:663598-66-1，1-((4-((5-Nitropyridin-2-yl)disulfanyl)pentanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
125 |
wyh |
2024-12-19 |
| 78727 |
cas:870487-10-8，Boc-Val-Cit-PAB-PNP，BOC-VAL-CIT-PAB-PNP 酯 |
117 |
kx |
2024-12-19 |
| 78728 |
cas:2353409-69-3 Mal-PEG8-Val-Cit-PAB-MMAE |
174 |
zyl |
2024-12-19 |
| 78729 |
cas:108852-90-0 Nemorubicin 奈莫柔比星 |
148 |
zyl |
2024-12-19 |
| 78730 |
cas:159858-22-7 ， Fmoc-Val-Cit-PAB-OH，ADC（抗体偶联药物） |
118 |
kx |
2024-12-19 |
| 78731 |
cas:1626359-59-8 磺基-SPDB-DM4 |
101 |
zyl |
2024-12-19 |
| 78732 |
cas:870487-09-5，Boc-Val-Cit-PAB， ADC试剂 |
92 |
kx |
2024-12-19 |
| 78733 |
NH2-Glu-Gly-Cit-PAB-OH， ADC试剂 |
165 |
kx |
2024-12-19 |
| 78734 |
sulfo-SPDB-DGN462，用于提高化合物的水溶性和稳定性 |
182 |
WYQ |
2024-12-19 |
| 78735 |
Fmoc-Gly-Gly-Phe-Gly-OH， ADC试剂 |
143 |
kx |
2024-12-19 |
| 78736 |
1342211-31-7，MC-Val-Ala-OH，马来酰亚胺基己酰-L-缬氨酰-L-丙氨酸，ADC连接子多肽 |
166 |
kx |
2024-12-19 |
| 78737 |
MA-PEG4-VC-PAB-DMAE-PNU159682（CAS号：2259318-52-8） |
118 |
WYQ |
2024-12-19 |
| 78738 |
MC-vc-PAB-C6-a-amanitin，一种抗体药物偶联物（ADC） |
129 |
WYQ |
2024-12-19 |
| 78739 |
cas:690632-55-4，N-Succinimidyloxycarbonylpropyl Methanethiosulfonate |
78 |
wyh |
2024-12-19 |
| 78740 |
VC-MMAF（CAS号：863971-17-9） |
120 |
WYQ |
2024-12-19 |
| 78741 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin-ADC抗体偶联药物 |
104 |
zyl |
2024-12-19 |
| 78742 |
2055024-62-7，NH2-PEG3-Val-Cit-PAB-OH， ADC试剂 |
106 |
kx |
2024-12-19 |
| 78743 |
cas:1834516-06-1 Fmoc-Ala-Ala-Asn-PABC-PNP |
121 |
zyl |
2024-12-19 |
| 78744 |
perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate |
138 |
wyh |
2024-12-19 |
| 78745 |
MC -Val-Cit， ADC试剂 |
179 |
kx |
2024-12-19 |
| 78746 |
cas:141534-26-1，2-(4-formylbenzamido)ethyl nitrate |
182 |
wyh |
2024-12-19 |
| 78747 |
cas:159857-81-5 Mc-Val-Cit-PABC-PNP |
125 |
zyl |
2024-12-19 |
| 78748 |
MC-PEG4-va-PAB-Exatecan， ADC试剂 |
211 |
kx |
2024-12-19 |
| 78749 |
cas:2101206-44-2 PY-DS-DMBUT-OPFP |
140 |
zyl |
2024-12-19 |
| 78750 |
Perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate |
89 |
wyh |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询